nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CYP2C9—Leflunomide—rheumatoid arthritis	0.0498	0.115	CbGbCtD
Paroxetine—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0394	0.0913	CbGbCtD
Paroxetine—CYP2C8—Hydrocortisone—rheumatoid arthritis	0.0354	0.0821	CbGbCtD
Paroxetine—CYP2C8—Cyclosporine—rheumatoid arthritis	0.0334	0.0775	CbGbCtD
Paroxetine—CYP2B6—Dexamethasone—rheumatoid arthritis	0.0291	0.0674	CbGbCtD
Paroxetine—ABCB1—Betamethasone—rheumatoid arthritis	0.0256	0.0594	CbGbCtD
Paroxetine—ABCB1—Prednisolone—rheumatoid arthritis	0.0253	0.0586	CbGbCtD
Paroxetine—ABCB1—Hydrocortisone—rheumatoid arthritis	0.024	0.0555	CbGbCtD
Paroxetine—ABCB1—Prednisone—rheumatoid arthritis	0.0239	0.0553	CbGbCtD
Paroxetine—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0233	0.054	CbGbCtD
Paroxetine—ABCB1—Cyclosporine—rheumatoid arthritis	0.0226	0.0525	CbGbCtD
Paroxetine—CYP2C8—Dexamethasone—rheumatoid arthritis	0.022	0.051	CbGbCtD
Paroxetine—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0213	0.0494	CbGbCtD
Paroxetine—CYP2C9—Dexamethasone—rheumatoid arthritis	0.0154	0.0356	CbGbCtD
Paroxetine—ABCB1—Dexamethasone—rheumatoid arthritis	0.0149	0.0345	CbGbCtD
Paroxetine—CYP2D6—Dexamethasone—rheumatoid arthritis	0.014	0.0325	CbGbCtD
Paroxetine—ABCB1—Methotrexate—rheumatoid arthritis	0.012	0.0278	CbGbCtD
Paroxetine—Hypotension—Methylprednisolone—rheumatoid arthritis	9.48e-05	0.000218	CcSEcCtD
Paroxetine—Pain—Prednisolone—rheumatoid arthritis	9.45e-05	0.000218	CcSEcCtD
Paroxetine—Haemorrhage—Methotrexate—rheumatoid arthritis	9.45e-05	0.000218	CcSEcCtD
Paroxetine—Hepatitis—Methotrexate—rheumatoid arthritis	9.45e-05	0.000218	CcSEcCtD
Paroxetine—Decreased appetite—Hydrocortisone—rheumatoid arthritis	9.38e-05	0.000216	CcSEcCtD
Paroxetine—Pharyngitis—Methotrexate—rheumatoid arthritis	9.38e-05	0.000216	CcSEcCtD
Paroxetine—Nausea—Leflunomide—rheumatoid arthritis	9.35e-05	0.000215	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	9.32e-05	0.000215	CcSEcCtD
Paroxetine—Fatigue—Hydrocortisone—rheumatoid arthritis	9.31e-05	0.000214	CcSEcCtD
Paroxetine—Vision blurred—Prednisone—rheumatoid arthritis	9.27e-05	0.000214	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	9.26e-05	0.000213	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	9.24e-05	0.000213	CcSEcCtD
Paroxetine—Pain—Hydrocortisone—rheumatoid arthritis	9.23e-05	0.000213	CcSEcCtD
Paroxetine—Anaphylactic shock—Betamethasone—rheumatoid arthritis	9.22e-05	0.000212	CcSEcCtD
Paroxetine—Oedema—Dexamethasone—rheumatoid arthritis	9.22e-05	0.000212	CcSEcCtD
Paroxetine—Oedema—Betamethasone—rheumatoid arthritis	9.22e-05	0.000212	CcSEcCtD
Paroxetine—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	9.22e-05	0.000212	CcSEcCtD
Paroxetine—Insomnia—Triamcinolone—rheumatoid arthritis	9.19e-05	0.000212	CcSEcCtD
Paroxetine—Insomnia—Methylprednisolone—rheumatoid arthritis	9.17e-05	0.000211	CcSEcCtD
Paroxetine—Infection—Dexamethasone—rheumatoid arthritis	9.16e-05	0.000211	CcSEcCtD
Paroxetine—Infection—Betamethasone—rheumatoid arthritis	9.16e-05	0.000211	CcSEcCtD
Paroxetine—Ill-defined disorder—Prednisone—rheumatoid arthritis	9.13e-05	0.00021	CcSEcCtD
Paroxetine—Paraesthesia—Triamcinolone—rheumatoid arthritis	9.13e-05	0.00021	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisolone—rheumatoid arthritis	9.11e-05	0.00021	CcSEcCtD
Paroxetine—Paraesthesia—Methylprednisolone—rheumatoid arthritis	9.11e-05	0.00021	CcSEcCtD
Paroxetine—Visual impairment—Methotrexate—rheumatoid arthritis	9.1e-05	0.00021	CcSEcCtD
Paroxetine—Anaemia—Prednisone—rheumatoid arthritis	9.1e-05	0.000209	CcSEcCtD
Paroxetine—Shock—Betamethasone—rheumatoid arthritis	9.07e-05	0.000209	CcSEcCtD
Paroxetine—Shock—Dexamethasone—rheumatoid arthritis	9.07e-05	0.000209	CcSEcCtD
Paroxetine—Dyspnoea—Triamcinolone—rheumatoid arthritis	9.06e-05	0.000209	CcSEcCtD
Paroxetine—Nervous system disorder—Betamethasone—rheumatoid arthritis	9.04e-05	0.000208	CcSEcCtD
Paroxetine—Nervous system disorder—Dexamethasone—rheumatoid arthritis	9.04e-05	0.000208	CcSEcCtD
Paroxetine—Agitation—Prednisone—rheumatoid arthritis	9.04e-05	0.000208	CcSEcCtD
Paroxetine—Thrombocytopenia—Betamethasone—rheumatoid arthritis	9.03e-05	0.000208	CcSEcCtD
Paroxetine—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	9.03e-05	0.000208	CcSEcCtD
Paroxetine—Tachycardia—Dexamethasone—rheumatoid arthritis	9e-05	0.000207	CcSEcCtD
Paroxetine—Tachycardia—Betamethasone—rheumatoid arthritis	9e-05	0.000207	CcSEcCtD
Paroxetine—Angioedema—Prednisone—rheumatoid arthritis	8.99e-05	0.000207	CcSEcCtD
Paroxetine—Hypersensitivity—Cyclosporine—rheumatoid arthritis	8.95e-05	0.000206	CcSEcCtD
Paroxetine—Dyspepsia—Triamcinolone—rheumatoid arthritis	8.95e-05	0.000206	CcSEcCtD
Paroxetine—Erythema multiforme—Methotrexate—rheumatoid arthritis	8.93e-05	0.000206	CcSEcCtD
Paroxetine—Dyspepsia—Methylprednisolone—rheumatoid arthritis	8.93e-05	0.000206	CcSEcCtD
Paroxetine—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	8.92e-05	0.000205	CcSEcCtD
Paroxetine—Hyperhidrosis—Betamethasone—rheumatoid arthritis	8.92e-05	0.000205	CcSEcCtD
Paroxetine—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	8.9e-05	0.000205	CcSEcCtD
Paroxetine—Malaise—Prednisone—rheumatoid arthritis	8.87e-05	0.000204	CcSEcCtD
Paroxetine—Vertigo—Prednisone—rheumatoid arthritis	8.84e-05	0.000204	CcSEcCtD
Paroxetine—Eye disorder—Methotrexate—rheumatoid arthritis	8.83e-05	0.000203	CcSEcCtD
Paroxetine—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	8.83e-05	0.000203	CcSEcCtD
Paroxetine—Syncope—Prednisone—rheumatoid arthritis	8.83e-05	0.000203	CcSEcCtD
Paroxetine—Tinnitus—Methotrexate—rheumatoid arthritis	8.81e-05	0.000203	CcSEcCtD
Paroxetine—Urticaria—Prednisolone—rheumatoid arthritis	8.78e-05	0.000202	CcSEcCtD
Paroxetine—Cardiac disorder—Methotrexate—rheumatoid arthritis	8.77e-05	0.000202	CcSEcCtD
Paroxetine—Fatigue—Triamcinolone—rheumatoid arthritis	8.76e-05	0.000202	CcSEcCtD
Paroxetine—Fatigue—Methylprednisolone—rheumatoid arthritis	8.74e-05	0.000201	CcSEcCtD
Paroxetine—Asthenia—Cyclosporine—rheumatoid arthritis	8.71e-05	0.000201	CcSEcCtD
Paroxetine—Pain—Triamcinolone—rheumatoid arthritis	8.69e-05	0.0002	CcSEcCtD
Paroxetine—Loss of consciousness—Prednisone—rheumatoid arthritis	8.65e-05	0.000199	CcSEcCtD
Paroxetine—Hypotension—Betamethasone—rheumatoid arthritis	8.62e-05	0.000198	CcSEcCtD
Paroxetine—Hypotension—Dexamethasone—rheumatoid arthritis	8.62e-05	0.000198	CcSEcCtD
Paroxetine—Pruritus—Cyclosporine—rheumatoid arthritis	8.59e-05	0.000198	CcSEcCtD
Paroxetine—Urticaria—Hydrocortisone—rheumatoid arthritis	8.58e-05	0.000197	CcSEcCtD
Paroxetine—Angiopathy—Methotrexate—rheumatoid arthritis	8.57e-05	0.000197	CcSEcCtD
Paroxetine—Immune system disorder—Methotrexate—rheumatoid arthritis	8.53e-05	0.000196	CcSEcCtD
Paroxetine—Abdominal pain—Hydrocortisone—rheumatoid arthritis	8.53e-05	0.000196	CcSEcCtD
Paroxetine—Body temperature increased—Hydrocortisone—rheumatoid arthritis	8.53e-05	0.000196	CcSEcCtD
Paroxetine—Convulsion—Prednisone—rheumatoid arthritis	8.53e-05	0.000196	CcSEcCtD
Paroxetine—Mediastinal disorder—Methotrexate—rheumatoid arthritis	8.51e-05	0.000196	CcSEcCtD
Paroxetine—Hypertension—Prednisone—rheumatoid arthritis	8.5e-05	0.000196	CcSEcCtD
Paroxetine—Chills—Methotrexate—rheumatoid arthritis	8.48e-05	0.000195	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	8.4e-05	0.000193	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	8.4e-05	0.000193	CcSEcCtD
Paroxetine—Myalgia—Prednisone—rheumatoid arthritis	8.38e-05	0.000193	CcSEcCtD
Paroxetine—Arthralgia—Prednisone—rheumatoid arthritis	8.38e-05	0.000193	CcSEcCtD
Paroxetine—Feeling abnormal—Triamcinolone—rheumatoid arthritis	8.38e-05	0.000193	CcSEcCtD
Paroxetine—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	8.36e-05	0.000192	CcSEcCtD
Paroxetine—Anxiety—Prednisone—rheumatoid arthritis	8.35e-05	0.000192	CcSEcCtD
Paroxetine—Alopecia—Methotrexate—rheumatoid arthritis	8.35e-05	0.000192	CcSEcCtD
Paroxetine—Insomnia—Betamethasone—rheumatoid arthritis	8.34e-05	0.000192	CcSEcCtD
Paroxetine—Insomnia—Dexamethasone—rheumatoid arthritis	8.34e-05	0.000192	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	8.32e-05	0.000192	CcSEcCtD
Paroxetine—Diarrhoea—Cyclosporine—rheumatoid arthritis	8.31e-05	0.000191	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	8.29e-05	0.000191	CcSEcCtD
Paroxetine—Paraesthesia—Dexamethasone—rheumatoid arthritis	8.28e-05	0.000191	CcSEcCtD
Paroxetine—Paraesthesia—Betamethasone—rheumatoid arthritis	8.28e-05	0.000191	CcSEcCtD
Paroxetine—Discomfort—Prednisone—rheumatoid arthritis	8.28e-05	0.000191	CcSEcCtD
Paroxetine—Mental disorder—Methotrexate—rheumatoid arthritis	8.28e-05	0.000191	CcSEcCtD
Paroxetine—Erythema—Methotrexate—rheumatoid arthritis	8.22e-05	0.000189	CcSEcCtD
Paroxetine—Malnutrition—Methotrexate—rheumatoid arthritis	8.22e-05	0.000189	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisolone—rheumatoid arthritis	8.14e-05	0.000187	CcSEcCtD
Paroxetine—Dyspepsia—Betamethasone—rheumatoid arthritis	8.12e-05	0.000187	CcSEcCtD
Paroxetine—Dyspepsia—Dexamethasone—rheumatoid arthritis	8.12e-05	0.000187	CcSEcCtD
Paroxetine—Urticaria—Triamcinolone—rheumatoid arthritis	8.07e-05	0.000186	CcSEcCtD
Paroxetine—Urticaria—Methylprednisolone—rheumatoid arthritis	8.06e-05	0.000185	CcSEcCtD
Paroxetine—Dysgeusia—Methotrexate—rheumatoid arthritis	8.05e-05	0.000185	CcSEcCtD
Paroxetine—Body temperature increased—Triamcinolone—rheumatoid arthritis	8.04e-05	0.000185	CcSEcCtD
Paroxetine—Dizziness—Cyclosporine—rheumatoid arthritis	8.03e-05	0.000185	CcSEcCtD
Paroxetine—Oedema—Prednisone—rheumatoid arthritis	8.03e-05	0.000185	CcSEcCtD
Paroxetine—Anaphylactic shock—Prednisone—rheumatoid arthritis	8.03e-05	0.000185	CcSEcCtD
Paroxetine—Abdominal pain—Methylprednisolone—rheumatoid arthritis	8.02e-05	0.000185	CcSEcCtD
Paroxetine—Decreased appetite—Betamethasone—rheumatoid arthritis	8.02e-05	0.000185	CcSEcCtD
Paroxetine—Decreased appetite—Dexamethasone—rheumatoid arthritis	8.02e-05	0.000185	CcSEcCtD
Paroxetine—Infection—Prednisone—rheumatoid arthritis	7.98e-05	0.000184	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	7.96e-05	0.000183	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	7.96e-05	0.000183	CcSEcCtD
Paroxetine—Back pain—Methotrexate—rheumatoid arthritis	7.96e-05	0.000183	CcSEcCtD
Paroxetine—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	7.95e-05	0.000183	CcSEcCtD
Paroxetine—Fatigue—Betamethasone—rheumatoid arthritis	7.95e-05	0.000183	CcSEcCtD
Paroxetine—Fatigue—Dexamethasone—rheumatoid arthritis	7.95e-05	0.000183	CcSEcCtD
Paroxetine—Shock—Prednisone—rheumatoid arthritis	7.9e-05	0.000182	CcSEcCtD
Paroxetine—Pain—Dexamethasone—rheumatoid arthritis	7.89e-05	0.000182	CcSEcCtD
Paroxetine—Pain—Betamethasone—rheumatoid arthritis	7.89e-05	0.000182	CcSEcCtD
Paroxetine—Nervous system disorder—Prednisone—rheumatoid arthritis	7.88e-05	0.000181	CcSEcCtD
Paroxetine—Tachycardia—Prednisone—rheumatoid arthritis	7.84e-05	0.00018	CcSEcCtD
Paroxetine—Skin disorder—Prednisone—rheumatoid arthritis	7.8e-05	0.00018	CcSEcCtD
Paroxetine—Hyperhidrosis—Prednisone—rheumatoid arthritis	7.76e-05	0.000179	CcSEcCtD
Paroxetine—Vision blurred—Methotrexate—rheumatoid arthritis	7.75e-05	0.000178	CcSEcCtD
Paroxetine—Asthenia—Hydrocortisone—rheumatoid arthritis	7.74e-05	0.000178	CcSEcCtD
Paroxetine—Vomiting—Cyclosporine—rheumatoid arthritis	7.72e-05	0.000178	CcSEcCtD
Paroxetine—Rash—Cyclosporine—rheumatoid arthritis	7.66e-05	0.000176	CcSEcCtD
Paroxetine—Dermatitis—Cyclosporine—rheumatoid arthritis	7.65e-05	0.000176	CcSEcCtD
Paroxetine—Pruritus—Hydrocortisone—rheumatoid arthritis	7.64e-05	0.000176	CcSEcCtD
Paroxetine—Ill-defined disorder—Methotrexate—rheumatoid arthritis	7.63e-05	0.000176	CcSEcCtD
Paroxetine—Headache—Cyclosporine—rheumatoid arthritis	7.61e-05	0.000175	CcSEcCtD
Paroxetine—Anaemia—Methotrexate—rheumatoid arthritis	7.6e-05	0.000175	CcSEcCtD
Paroxetine—Feeling abnormal—Betamethasone—rheumatoid arthritis	7.6e-05	0.000175	CcSEcCtD
Paroxetine—Feeling abnormal—Dexamethasone—rheumatoid arthritis	7.6e-05	0.000175	CcSEcCtD
Paroxetine—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	7.54e-05	0.000174	CcSEcCtD
Paroxetine—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	7.54e-05	0.000174	CcSEcCtD
Paroxetine—Hypersensitivity—Triamcinolone—rheumatoid arthritis	7.49e-05	0.000172	CcSEcCtD
Paroxetine—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	7.47e-05	0.000172	CcSEcCtD
Paroxetine—Malaise—Methotrexate—rheumatoid arthritis	7.42e-05	0.000171	CcSEcCtD
Paroxetine—Vertigo—Methotrexate—rheumatoid arthritis	7.39e-05	0.00017	CcSEcCtD
Paroxetine—Diarrhoea—Hydrocortisone—rheumatoid arthritis	7.39e-05	0.00017	CcSEcCtD
Paroxetine—Leukopenia—Methotrexate—rheumatoid arthritis	7.36e-05	0.000169	CcSEcCtD
Paroxetine—Urticaria—Dexamethasone—rheumatoid arthritis	7.33e-05	0.000169	CcSEcCtD
Paroxetine—Urticaria—Betamethasone—rheumatoid arthritis	7.33e-05	0.000169	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	7.32e-05	0.000168	CcSEcCtD
Paroxetine—Dizziness—Prednisolone—rheumatoid arthritis	7.31e-05	0.000168	CcSEcCtD
Paroxetine—Asthenia—Triamcinolone—rheumatoid arthritis	7.29e-05	0.000168	CcSEcCtD
Paroxetine—Abdominal pain—Dexamethasone—rheumatoid arthritis	7.29e-05	0.000168	CcSEcCtD
Paroxetine—Abdominal pain—Betamethasone—rheumatoid arthritis	7.29e-05	0.000168	CcSEcCtD
Paroxetine—Body temperature increased—Betamethasone—rheumatoid arthritis	7.29e-05	0.000168	CcSEcCtD
Paroxetine—Body temperature increased—Dexamethasone—rheumatoid arthritis	7.29e-05	0.000168	CcSEcCtD
Paroxetine—Asthenia—Methylprednisolone—rheumatoid arthritis	7.28e-05	0.000168	CcSEcCtD
Paroxetine—Insomnia—Prednisone—rheumatoid arthritis	7.26e-05	0.000167	CcSEcCtD
Paroxetine—Nausea—Cyclosporine—rheumatoid arthritis	7.21e-05	0.000166	CcSEcCtD
Paroxetine—Paraesthesia—Prednisone—rheumatoid arthritis	7.21e-05	0.000166	CcSEcCtD
Paroxetine—Pruritus—Triamcinolone—rheumatoid arthritis	7.19e-05	0.000166	CcSEcCtD
Paroxetine—Cough—Methotrexate—rheumatoid arthritis	7.18e-05	0.000165	CcSEcCtD
Paroxetine—Pruritus—Methylprednisolone—rheumatoid arthritis	7.18e-05	0.000165	CcSEcCtD
Paroxetine—Dizziness—Hydrocortisone—rheumatoid arthritis	7.14e-05	0.000164	CcSEcCtD
Paroxetine—Convulsion—Methotrexate—rheumatoid arthritis	7.13e-05	0.000164	CcSEcCtD
Paroxetine—Dyspepsia—Prednisone—rheumatoid arthritis	7.07e-05	0.000163	CcSEcCtD
Paroxetine—Arthralgia—Methotrexate—rheumatoid arthritis	7e-05	0.000161	CcSEcCtD
Paroxetine—Myalgia—Methotrexate—rheumatoid arthritis	7e-05	0.000161	CcSEcCtD
Paroxetine—Chest pain—Methotrexate—rheumatoid arthritis	7e-05	0.000161	CcSEcCtD
Paroxetine—Decreased appetite—Prednisone—rheumatoid arthritis	6.98e-05	0.000161	CcSEcCtD
Paroxetine—Rash—Prednisolone—rheumatoid arthritis	6.97e-05	0.00016	CcSEcCtD
Paroxetine—Dermatitis—Prednisolone—rheumatoid arthritis	6.96e-05	0.00016	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	6.95e-05	0.00016	CcSEcCtD
Paroxetine—Diarrhoea—Methylprednisolone—rheumatoid arthritis	6.94e-05	0.00016	CcSEcCtD
Paroxetine—Fatigue—Prednisone—rheumatoid arthritis	6.92e-05	0.000159	CcSEcCtD
Paroxetine—Headache—Prednisolone—rheumatoid arthritis	6.92e-05	0.000159	CcSEcCtD
Paroxetine—Discomfort—Methotrexate—rheumatoid arthritis	6.92e-05	0.000159	CcSEcCtD
Paroxetine—Constipation—Prednisone—rheumatoid arthritis	6.87e-05	0.000158	CcSEcCtD
Paroxetine—Vomiting—Hydrocortisone—rheumatoid arthritis	6.86e-05	0.000158	CcSEcCtD
Paroxetine—Rash—Hydrocortisone—rheumatoid arthritis	6.81e-05	0.000157	CcSEcCtD
Paroxetine—Dermatitis—Hydrocortisone—rheumatoid arthritis	6.8e-05	0.000157	CcSEcCtD
Paroxetine—Confusional state—Methotrexate—rheumatoid arthritis	6.77e-05	0.000156	CcSEcCtD
Paroxetine—Headache—Hydrocortisone—rheumatoid arthritis	6.76e-05	0.000156	CcSEcCtD
Paroxetine—Dizziness—Triamcinolone—rheumatoid arthritis	6.72e-05	0.000155	CcSEcCtD
Paroxetine—Anaphylactic shock—Methotrexate—rheumatoid arthritis	6.71e-05	0.000155	CcSEcCtD
Paroxetine—Dizziness—Methylprednisolone—rheumatoid arthritis	6.71e-05	0.000154	CcSEcCtD
Paroxetine—Infection—Methotrexate—rheumatoid arthritis	6.67e-05	0.000154	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisone—rheumatoid arthritis	6.62e-05	0.000152	CcSEcCtD
Paroxetine—Asthenia—Dexamethasone—rheumatoid arthritis	6.62e-05	0.000152	CcSEcCtD
Paroxetine—Asthenia—Betamethasone—rheumatoid arthritis	6.62e-05	0.000152	CcSEcCtD
Paroxetine—Nervous system disorder—Methotrexate—rheumatoid arthritis	6.58e-05	0.000152	CcSEcCtD
Paroxetine—Thrombocytopenia—Methotrexate—rheumatoid arthritis	6.57e-05	0.000151	CcSEcCtD
Paroxetine—Gastrointestinal pain—Prednisone—rheumatoid arthritis	6.57e-05	0.000151	CcSEcCtD
Paroxetine—Nausea—Prednisolone—rheumatoid arthritis	6.57e-05	0.000151	CcSEcCtD
Paroxetine—Pruritus—Betamethasone—rheumatoid arthritis	6.52e-05	0.00015	CcSEcCtD
Paroxetine—Pruritus—Dexamethasone—rheumatoid arthritis	6.52e-05	0.00015	CcSEcCtD
Paroxetine—Skin disorder—Methotrexate—rheumatoid arthritis	6.52e-05	0.00015	CcSEcCtD
Paroxetine—Hyperhidrosis—Methotrexate—rheumatoid arthritis	6.49e-05	0.000149	CcSEcCtD
Paroxetine—Vomiting—Triamcinolone—rheumatoid arthritis	6.46e-05	0.000149	CcSEcCtD
Paroxetine—Vomiting—Methylprednisolone—rheumatoid arthritis	6.45e-05	0.000148	CcSEcCtD
Paroxetine—Nausea—Hydrocortisone—rheumatoid arthritis	6.41e-05	0.000148	CcSEcCtD
Paroxetine—Rash—Triamcinolone—rheumatoid arthritis	6.41e-05	0.000148	CcSEcCtD
Paroxetine—Dermatitis—Triamcinolone—rheumatoid arthritis	6.4e-05	0.000147	CcSEcCtD
Paroxetine—Rash—Methylprednisolone—rheumatoid arthritis	6.39e-05	0.000147	CcSEcCtD
Paroxetine—Dermatitis—Methylprednisolone—rheumatoid arthritis	6.39e-05	0.000147	CcSEcCtD
Paroxetine—Urticaria—Prednisone—rheumatoid arthritis	6.38e-05	0.000147	CcSEcCtD
Paroxetine—Headache—Triamcinolone—rheumatoid arthritis	6.37e-05	0.000147	CcSEcCtD
Paroxetine—Headache—Methylprednisolone—rheumatoid arthritis	6.35e-05	0.000146	CcSEcCtD
Paroxetine—Abdominal pain—Prednisone—rheumatoid arthritis	6.35e-05	0.000146	CcSEcCtD
Paroxetine—Body temperature increased—Prednisone—rheumatoid arthritis	6.35e-05	0.000146	CcSEcCtD
Paroxetine—Diarrhoea—Betamethasone—rheumatoid arthritis	6.31e-05	0.000145	CcSEcCtD
Paroxetine—Diarrhoea—Dexamethasone—rheumatoid arthritis	6.31e-05	0.000145	CcSEcCtD
Paroxetine—Hypotension—Methotrexate—rheumatoid arthritis	6.27e-05	0.000144	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	6.12e-05	0.000141	CcSEcCtD
Paroxetine—Dizziness—Betamethasone—rheumatoid arthritis	6.1e-05	0.00014	CcSEcCtD
Paroxetine—Dizziness—Dexamethasone—rheumatoid arthritis	6.1e-05	0.00014	CcSEcCtD
Paroxetine—Insomnia—Methotrexate—rheumatoid arthritis	6.07e-05	0.00014	CcSEcCtD
Paroxetine—Nausea—Triamcinolone—rheumatoid arthritis	6.04e-05	0.000139	CcSEcCtD
Paroxetine—Paraesthesia—Methotrexate—rheumatoid arthritis	6.03e-05	0.000139	CcSEcCtD
Paroxetine—Nausea—Methylprednisolone—rheumatoid arthritis	6.02e-05	0.000139	CcSEcCtD
Paroxetine—Dyspnoea—Methotrexate—rheumatoid arthritis	5.98e-05	0.000138	CcSEcCtD
Paroxetine—Somnolence—Methotrexate—rheumatoid arthritis	5.97e-05	0.000137	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisone—rheumatoid arthritis	5.92e-05	0.000136	CcSEcCtD
Paroxetine—Dyspepsia—Methotrexate—rheumatoid arthritis	5.91e-05	0.000136	CcSEcCtD
Paroxetine—Vomiting—Dexamethasone—rheumatoid arthritis	5.86e-05	0.000135	CcSEcCtD
Paroxetine—Vomiting—Betamethasone—rheumatoid arthritis	5.86e-05	0.000135	CcSEcCtD
Paroxetine—Decreased appetite—Methotrexate—rheumatoid arthritis	5.83e-05	0.000134	CcSEcCtD
Paroxetine—Rash—Dexamethasone—rheumatoid arthritis	5.81e-05	0.000134	CcSEcCtD
Paroxetine—Rash—Betamethasone—rheumatoid arthritis	5.81e-05	0.000134	CcSEcCtD
Paroxetine—Dermatitis—Betamethasone—rheumatoid arthritis	5.81e-05	0.000134	CcSEcCtD
Paroxetine—Dermatitis—Dexamethasone—rheumatoid arthritis	5.81e-05	0.000134	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	5.79e-05	0.000133	CcSEcCtD
Paroxetine—Fatigue—Methotrexate—rheumatoid arthritis	5.79e-05	0.000133	CcSEcCtD
Paroxetine—Headache—Dexamethasone—rheumatoid arthritis	5.78e-05	0.000133	CcSEcCtD
Paroxetine—Headache—Betamethasone—rheumatoid arthritis	5.78e-05	0.000133	CcSEcCtD
Paroxetine—Asthenia—Prednisone—rheumatoid arthritis	5.76e-05	0.000133	CcSEcCtD
Paroxetine—Pain—Methotrexate—rheumatoid arthritis	5.74e-05	0.000132	CcSEcCtD
Paroxetine—Pruritus—Prednisone—rheumatoid arthritis	5.68e-05	0.000131	CcSEcCtD
Paroxetine—Feeling abnormal—Methotrexate—rheumatoid arthritis	5.53e-05	0.000127	CcSEcCtD
Paroxetine—Diarrhoea—Prednisone—rheumatoid arthritis	5.5e-05	0.000127	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	5.49e-05	0.000126	CcSEcCtD
Paroxetine—Nausea—Dexamethasone—rheumatoid arthritis	5.48e-05	0.000126	CcSEcCtD
Paroxetine—Nausea—Betamethasone—rheumatoid arthritis	5.48e-05	0.000126	CcSEcCtD
Paroxetine—Urticaria—Methotrexate—rheumatoid arthritis	5.33e-05	0.000123	CcSEcCtD
Paroxetine—Dizziness—Prednisone—rheumatoid arthritis	5.31e-05	0.000122	CcSEcCtD
Paroxetine—Body temperature increased—Methotrexate—rheumatoid arthritis	5.31e-05	0.000122	CcSEcCtD
Paroxetine—Abdominal pain—Methotrexate—rheumatoid arthritis	5.31e-05	0.000122	CcSEcCtD
Paroxetine—Vomiting—Prednisone—rheumatoid arthritis	5.11e-05	0.000118	CcSEcCtD
Paroxetine—Rash—Prednisone—rheumatoid arthritis	5.06e-05	0.000117	CcSEcCtD
Paroxetine—Dermatitis—Prednisone—rheumatoid arthritis	5.06e-05	0.000116	CcSEcCtD
Paroxetine—Headache—Prednisone—rheumatoid arthritis	5.03e-05	0.000116	CcSEcCtD
Paroxetine—Hypersensitivity—Methotrexate—rheumatoid arthritis	4.95e-05	0.000114	CcSEcCtD
Paroxetine—Asthenia—Methotrexate—rheumatoid arthritis	4.82e-05	0.000111	CcSEcCtD
Paroxetine—Nausea—Prednisone—rheumatoid arthritis	4.77e-05	0.00011	CcSEcCtD
Paroxetine—Pruritus—Methotrexate—rheumatoid arthritis	4.75e-05	0.000109	CcSEcCtD
Paroxetine—Diarrhoea—Methotrexate—rheumatoid arthritis	4.59e-05	0.000106	CcSEcCtD
Paroxetine—Dizziness—Methotrexate—rheumatoid arthritis	4.44e-05	0.000102	CcSEcCtD
Paroxetine—Vomiting—Methotrexate—rheumatoid arthritis	4.27e-05	9.83e-05	CcSEcCtD
Paroxetine—Rash—Methotrexate—rheumatoid arthritis	4.23e-05	9.74e-05	CcSEcCtD
Paroxetine—Dermatitis—Methotrexate—rheumatoid arthritis	4.23e-05	9.73e-05	CcSEcCtD
Paroxetine—Headache—Methotrexate—rheumatoid arthritis	4.21e-05	9.68e-05	CcSEcCtD
Paroxetine—Nausea—Methotrexate—rheumatoid arthritis	3.99e-05	9.18e-05	CcSEcCtD
Paroxetine—CYP2C8—Metabolism—ENO1—rheumatoid arthritis	1.55e-05	0.000115	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	1.54e-05	0.000115	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL2RA—rheumatoid arthritis	1.53e-05	0.000114	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—CAT—rheumatoid arthritis	1.53e-05	0.000114	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.52e-05	0.000113	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL2—rheumatoid arthritis	1.52e-05	0.000113	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—C3—rheumatoid arthritis	1.52e-05	0.000113	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.5e-05	0.000112	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SYK—rheumatoid arthritis	1.49e-05	0.000111	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.49e-05	0.000111	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SYK—rheumatoid arthritis	1.48e-05	0.000111	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.48e-05	0.000111	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SYK—rheumatoid arthritis	1.48e-05	0.00011	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—LEP—rheumatoid arthritis	1.48e-05	0.00011	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.47e-05	0.00011	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SYK—rheumatoid arthritis	1.47e-05	0.000109	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.47e-05	0.000109	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.46e-05	0.000109	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—POMC—rheumatoid arthritis	1.46e-05	0.000108	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.45e-05	0.000108	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—POMC—rheumatoid arthritis	1.45e-05	0.000108	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—POMC—rheumatoid arthritis	1.44e-05	0.000108	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—STAT1—rheumatoid arthritis	1.44e-05	0.000107	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.44e-05	0.000107	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—STAT1—rheumatoid arthritis	1.43e-05	0.000107	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—POMC—rheumatoid arthritis	1.43e-05	0.000106	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—STAT1—rheumatoid arthritis	1.43e-05	0.000106	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CCL2—rheumatoid arthritis	1.42e-05	0.000106	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL6R—rheumatoid arthritis	1.42e-05	0.000106	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL10—rheumatoid arthritis	1.42e-05	0.000106	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CCL2—rheumatoid arthritis	1.42e-05	0.000106	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—LEP—rheumatoid arthritis	1.41e-05	0.000105	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—STAT1—rheumatoid arthritis	1.41e-05	0.000105	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL6R—rheumatoid arthritis	1.41e-05	0.000105	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CCL2—rheumatoid arthritis	1.41e-05	0.000105	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL10—rheumatoid arthritis	1.41e-05	0.000105	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL6R—rheumatoid arthritis	1.41e-05	0.000105	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL10—rheumatoid arthritis	1.41e-05	0.000105	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CCL2—rheumatoid arthritis	1.4e-05	0.000104	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL6R—rheumatoid arthritis	1.39e-05	0.000104	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL10—rheumatoid arthritis	1.39e-05	0.000104	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—FN1—rheumatoid arthritis	1.39e-05	0.000104	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6ST—rheumatoid arthritis	1.39e-05	0.000103	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.36e-05	0.000101	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ENO1—rheumatoid arthritis	1.35e-05	0.0001	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CD80—rheumatoid arthritis	1.34e-05	9.95e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—FN1—rheumatoid arthritis	1.33e-05	9.94e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.33e-05	9.91e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6ST—rheumatoid arthritis	1.33e-05	9.9e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—CAT—rheumatoid arthritis	1.31e-05	9.79e-05	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TP53—rheumatoid arthritis	1.31e-05	9.77e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MMP3—rheumatoid arthritis	1.29e-05	9.64e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—TYK2—rheumatoid arthritis	1.29e-05	9.64e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MMP3—rheumatoid arthritis	1.29e-05	9.59e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—TYK2—rheumatoid arthritis	1.29e-05	9.58e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MMP3—rheumatoid arthritis	1.28e-05	9.56e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—TYK2—rheumatoid arthritis	1.28e-05	9.55e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CD80—rheumatoid arthritis	1.28e-05	9.53e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—MTHFR—rheumatoid arthritis	1.28e-05	9.5e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MMP3—rheumatoid arthritis	1.27e-05	9.47e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—TYK2—rheumatoid arthritis	1.27e-05	9.46e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	1.27e-05	9.45e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—POMC—rheumatoid arthritis	1.27e-05	9.45e-05	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	1.26e-05	9.38e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	1.26e-05	9.37e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PTK2—rheumatoid arthritis	1.25e-05	9.28e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CCL2—rheumatoid arthritis	1.24e-05	9.25e-05	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.24e-05	9.24e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PTK2—rheumatoid arthritis	1.24e-05	9.23e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6R—rheumatoid arthritis	1.24e-05	9.22e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.24e-05	9.22e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PTK2—rheumatoid arthritis	1.24e-05	9.2e-05	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.23e-05	9.19e-05	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.23e-05	9.16e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PTK2—rheumatoid arthritis	1.22e-05	9.11e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCL5—rheumatoid arthritis	1.22e-05	9.1e-05	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.22e-05	9.07e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—POMC—rheumatoid arthritis	1.22e-05	9.05e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCL5—rheumatoid arthritis	1.22e-05	9.05e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL5—rheumatoid arthritis	1.21e-05	9.02e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CSF2—rheumatoid arthritis	1.2e-05	8.96e-05	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL6—rheumatoid arthritis	1.2e-05	8.94e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL5—rheumatoid arthritis	1.2e-05	8.93e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CSF2—rheumatoid arthritis	1.2e-05	8.91e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CSF2—rheumatoid arthritis	1.19e-05	8.89e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CCL2—rheumatoid arthritis	1.19e-05	8.86e-05	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL2—rheumatoid arthritis	1.19e-05	8.83e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6R—rheumatoid arthritis	1.19e-05	8.83e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CSF2—rheumatoid arthritis	1.18e-05	8.8e-05	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL2—rheumatoid arthritis	1.18e-05	8.78e-05	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL2—rheumatoid arthritis	1.18e-05	8.75e-05	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL2—rheumatoid arthritis	1.16e-05	8.67e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SPP1—rheumatoid arthritis	1.13e-05	8.43e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TYK2—rheumatoid arthritis	1.13e-05	8.4e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.13e-05	8.39e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SPP1—rheumatoid arthritis	1.13e-05	8.38e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SPP1—rheumatoid arthritis	1.12e-05	8.35e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.12e-05	8.34e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.12e-05	8.32e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CAT—rheumatoid arthritis	1.11e-05	8.29e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SPP1—rheumatoid arthritis	1.11e-05	8.27e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NOS3—rheumatoid arthritis	1.11e-05	8.24e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.11e-05	8.24e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCR5—rheumatoid arthritis	1.1e-05	8.2e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—MTHFR—rheumatoid arthritis	1.1e-05	8.17e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCR5—rheumatoid arthritis	1.09e-05	8.15e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCR5—rheumatoid arthritis	1.09e-05	8.13e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2RA—rheumatoid arthritis	1.08e-05	8.08e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.08e-05	8.06e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCR5—rheumatoid arthritis	1.08e-05	8.05e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TYK2—rheumatoid arthritis	1.08e-05	8.04e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2RA—rheumatoid arthritis	1.08e-05	8.04e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL2—rheumatoid arthritis	1.08e-05	8.02e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—C3—rheumatoid arthritis	1.08e-05	8.01e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2RA—rheumatoid arthritis	1.08e-05	8.01e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL2—rheumatoid arthritis	1.07e-05	7.97e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—C3—rheumatoid arthritis	1.07e-05	7.97e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL2—rheumatoid arthritis	1.07e-05	7.95e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—C3—rheumatoid arthritis	1.07e-05	7.94e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2RA—rheumatoid arthritis	1.07e-05	7.93e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NOS3—rheumatoid arthritis	1.06e-05	7.89e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL2—rheumatoid arthritis	1.06e-05	7.87e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—C3—rheumatoid arthritis	1.06e-05	7.87e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—POMC—rheumatoid arthritis	1.02e-05	7.6e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—LEP—rheumatoid arthritis	1e-05	7.46e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—LEP—rheumatoid arthritis	9.96e-06	7.42e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—LEP—rheumatoid arthritis	9.93e-06	7.39e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—LEP—rheumatoid arthritis	9.83e-06	7.32e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CXCL8—rheumatoid arthritis	9.82e-06	7.31e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CAT—rheumatoid arthritis	9.7e-06	7.22e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—FN1—rheumatoid arthritis	9.44e-06	7.03e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6ST—rheumatoid arthritis	9.41e-06	7e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CXCL8—rheumatoid arthritis	9.4e-06	7e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—FN1—rheumatoid arthritis	9.39e-06	7e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL2—rheumatoid arthritis	9.38e-06	6.99e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—FN1—rheumatoid arthritis	9.36e-06	6.97e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6ST—rheumatoid arthritis	9.35e-06	6.97e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL6—rheumatoid arthritis	9.33e-06	6.95e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6ST—rheumatoid arthritis	9.32e-06	6.95e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ALB—rheumatoid arthritis	9.3e-06	6.93e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—MTHFR—rheumatoid arthritis	9.29e-06	6.92e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—FN1—rheumatoid arthritis	9.27e-06	6.91e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6ST—rheumatoid arthritis	9.23e-06	6.88e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CAT—rheumatoid arthritis	9.14e-06	6.81e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CAT—rheumatoid arthritis	9.06e-06	6.75e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CD80—rheumatoid arthritis	9.05e-06	6.74e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CD80—rheumatoid arthritis	9e-06	6.71e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL2—rheumatoid arthritis	8.98e-06	6.69e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CD80—rheumatoid arthritis	8.98e-06	6.69e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL6—rheumatoid arthritis	8.94e-06	6.66e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—NOS3—rheumatoid arthritis	8.89e-06	6.62e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CD80—rheumatoid arthritis	8.89e-06	6.62e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MMP9—rheumatoid arthritis	8.88e-06	6.61e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NFKB1—rheumatoid arthritis	8.78e-06	6.54e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—POMC—rheumatoid arthritis	8.77e-06	6.54e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MAPK8—rheumatoid arthritis	8.63e-06	6.43e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—POMC—rheumatoid arthritis	8.6e-06	6.41e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—POMC—rheumatoid arthritis	8.56e-06	6.37e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—POMC—rheumatoid arthritis	8.53e-06	6.35e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MMP9—rheumatoid arthritis	8.5e-06	6.33e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—POMC—rheumatoid arthritis	8.45e-06	6.29e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	8.42e-06	6.27e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NFKB1—rheumatoid arthritis	8.41e-06	6.27e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	8.39e-06	6.25e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCL2—rheumatoid arthritis	8.37e-06	6.23e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6R—rheumatoid arthritis	8.35e-06	6.22e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL2—rheumatoid arthritis	8.34e-06	6.22e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6R—rheumatoid arthritis	8.32e-06	6.2e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MAPK8—rheumatoid arthritis	8.27e-06	6.16e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL2—rheumatoid arthritis	8.26e-06	6.15e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6R—rheumatoid arthritis	8.24e-06	6.14e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTGS2—rheumatoid arthritis	8.14e-06	6.06e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	8.09e-06	6.03e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ALB—rheumatoid arthritis	8e-06	5.96e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—VEGFA—rheumatoid arthritis	7.97e-06	5.94e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—NOS3—rheumatoid arthritis	7.65e-06	5.7e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	7.64e-06	5.69e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—VEGFA—rheumatoid arthritis	7.63e-06	5.69e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	7.63e-06	5.68e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TYK2—rheumatoid arthritis	7.6e-06	5.66e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TYK2—rheumatoid arthritis	7.58e-06	5.64e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	7.56e-06	5.63e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TYK2—rheumatoid arthritis	7.5e-06	5.59e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	7.5e-06	5.59e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NOS3—rheumatoid arthritis	7.46e-06	5.56e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NOS3—rheumatoid arthritis	7.44e-06	5.54e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—POMC—rheumatoid arthritis	7.43e-06	5.53e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NOS3—rheumatoid arthritis	7.37e-06	5.49e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TGFB1—rheumatoid arthritis	7.32e-06	5.45e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TGFB1—rheumatoid arthritis	7.01e-06	5.22e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTGS2—rheumatoid arthritis	7e-06	5.21e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ALB—rheumatoid arthritis	6.77e-06	5.04e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	6.65e-06	4.96e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	6.62e-06	4.93e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL8—rheumatoid arthritis	6.6e-06	4.91e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL8—rheumatoid arthritis	6.53e-06	4.87e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—NOS3—rheumatoid arthritis	6.48e-06	4.83e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—POMC—rheumatoid arthritis	6.47e-06	4.82e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	6.36e-06	4.74e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	6.33e-06	4.71e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2—rheumatoid arthritis	6.33e-06	4.71e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2—rheumatoid arthritis	6.31e-06	4.7e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL6—rheumatoid arthritis	6.29e-06	4.69e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL6—rheumatoid arthritis	6.27e-06	4.67e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2—rheumatoid arthritis	6.24e-06	4.65e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL6—rheumatoid arthritis	6.21e-06	4.63e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—POMC—rheumatoid arthritis	6.1e-06	4.54e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—POMC—rheumatoid arthritis	6.05e-06	4.5e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TP53—rheumatoid arthritis	6.02e-06	4.49e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	6.02e-06	4.48e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MMP9—rheumatoid arthritis	5.99e-06	4.46e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MMP9—rheumatoid arthritis	5.97e-06	4.44e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	5.95e-06	4.44e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTGS2—rheumatoid arthritis	5.93e-06	4.41e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	5.92e-06	4.41e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MMP9—rheumatoid arthritis	5.91e-06	4.4e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NFKB1—rheumatoid arthritis	5.9e-06	4.4e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ALB—rheumatoid arthritis	5.9e-06	4.39e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	5.85e-06	4.36e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NFKB1—rheumatoid arthritis	5.85e-06	4.35e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	5.82e-06	4.34e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MAPK8—rheumatoid arthritis	5.8e-06	4.32e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TP53—rheumatoid arthritis	5.77e-06	4.3e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MAPK8—rheumatoid arthritis	5.75e-06	4.28e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—NOS3—rheumatoid arthritis	5.64e-06	4.2e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ALB—rheumatoid arthritis	5.56e-06	4.14e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6—rheumatoid arthritis	5.51e-06	4.11e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ALB—rheumatoid arthritis	5.51e-06	4.11e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	5.4e-06	4.03e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	5.38e-06	4e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—VEGFA—rheumatoid arthritis	5.36e-06	3.99e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	5.32e-06	3.96e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—VEGFA—rheumatoid arthritis	5.31e-06	3.95e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6—rheumatoid arthritis	5.28e-06	3.93e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	5.27e-06	3.93e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	5.16e-06	3.84e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	4.96e-06	3.69e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	4.93e-06	3.67e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TGFB1—rheumatoid arthritis	4.92e-06	3.66e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TGFB1—rheumatoid arthritis	4.87e-06	3.63e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	4.86e-06	3.62e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	4.82e-06	3.59e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	4.08e-06	3.04e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TP53—rheumatoid arthritis	4.06e-06	3.03e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TP53—rheumatoid arthritis	4.05e-06	3.02e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TP53—rheumatoid arthritis	4.01e-06	2.99e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	3.74e-06	2.78e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6—rheumatoid arthritis	3.72e-06	2.77e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6—rheumatoid arthritis	3.71e-06	2.76e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6—rheumatoid arthritis	3.67e-06	2.73e-05	CbGpPWpGaD
